Identity
- Trade Name
- Serological Pipette 1 mL EUDAMED
- Device Name
- ART Pipette EUDAMED
- Model / Reference
- TD20 EUDAMED113701 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 08717973714538 EUDAMED
- Basic UDI-DI
- 87179737120YQ EUDAMED
- Direct Marketing DI
- 08717973714538 EUDAMED
- EMDN Code
- U080299 DEVICES FOR ASSISTED REPRODUCTION - OTHER EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- Belgium EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Category: Assisted reproduction vitrification carrier
Serological Pipette 1 mL by BIRR Biosciences BV — Class IIa — MDR — listed in EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Assisted reproduction vitrification carrier.
- S-CRYOLOCK (B) — BIOTECH INCORPORATED · Class II
- VitriGuard — Origio A/S · Class II
- Dry Incubator / EC6S-230MR — ASTEC CO.,Ltd · Class IIa
- CRYOPETTE — ORIGIO INC. · Class II
- Kryo 500 Series Controlled Rate Freezer — PLANER LIMITED · Class I
- VitriGuard — Origio A/S · Class II
- CRYOPETTE — ORIGIO INC. · Class II
- S-CRYOLOCK (G) — BIOTECH INCORPORATED · Class II
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 87179737120YQ | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- BIRR Biosciences BV
- EUDAMED SRN
- NL-MF-000023194
Sources (2)
- EUDAMED 5dde17e3-5855-4e11-9473-84fa92328d82 61 fields · synced Jul 15, 2026
- EUDAMED 6594ea7c-7b30-46c8-8c7d-a1fa3930bbfc 61 fields · synced Jun 14, 2026